• Bloomberg: Potential of green investing

    9 days ago - By Green Light Biosciences

    GreenLight Biosciences feature in Bloomberg in a piece focused on investor Jeremy Grantham and the potential of green investing.

    GreenLight Biosciences feature in Bloomberg in a piece focused on investor Jeremy Grantham. It highlights the potential of green investing and Greenlight's work on RNA alternatives to pesticides. An extract from the article is below:
    Greenlight Biosciences, Grantham's second-largest direct investment, makes RNA molecules designed to be an environmentally friendly alternative to pesticides. In August, the firm said it's going public via a SPAC.
    Read the full...
    Read more ...